The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Pulmonary Arterial Hypertension
Abstract
Without effective treatment, pulmonary arterial hypertension results in high morbidity and mortality. This review discusses the pathogenesis of the disorder, the thorough clinical evaluation required to establish the diagnosis, available therapies, and future directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Barst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Pulmonary Arterial Hypertension in France: Results from a National Registry
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1668oc · Cited by 2,000
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Lane, K. B., Machado, R. D., Pauciulo, M. W., Thomson, J. R., Phillips, J. A., Loyd, J. E., Nichols, W. C., & Trembath, R. C. (2000) · Nature Genetics · doi:10.1038/79226 · Cited by 1,495
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Pulido, T., Adzerikho, I., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H.-A., Jansa, P., Jing, Z.-C., Le Brun, F.-O., Mehta, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213917 · Cited by 1,443
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.911818 · Cited by 1,399
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,255
Deng, Z., Morse, J. H., Slager, S. L., Cuervo, N., Moore, K. J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S. G., Barst, R. J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/303059 · Cited by 1,206
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Galiè, N., Barberà, J. A., Frost, A. E., Ghofrani, H.-A., Hoeper, M. M., McLaughlin, V. V., Peacock, A. J., Simonneau, G., Vachiery, J.-L., Grünig, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413687 · Cited by 1,182
Benza, R. L., Miller, D. P., Barst, R. J., Badesch, D. B., Frost, A. E., & McGoon, M. D. (2012) · Chest · doi:10.1378/chest.11-1460 · Cited by 1,104
Primary pulmonary hypertension: natural history and the importance of thrombosis.
Fuster, V, Steele, P. M., Edwards, W. D., Gersh, B. J., McGoon, M. D., & Frye, R. L. (1984) · Circulation · doi:10.1161/01.cir.70.4.580 · Cited by 1,066
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R., Chin, K. M., Frey, A., Gaine, S., Galiè, N., Ghofrani, H.-A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,060
A global view of pulmonary hypertension
Hoeper, M. M., Humbert, M., Souza, R., Idrees, M., Kawut, S. M., Sliwa-Hahnle, K., Jing, Z.-C., & Gibbs, J. S. R. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00543-3 · Cited by 1,039
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
Coghlan, J. G., Denton, C. P., Grünig, E., Bonderman, D., Distler, O., Khanna, D., Müller-Ladner, U., Pope, J. E., Vonk, M. C., Doelberg, M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203301 · Cited by 832
Risk stratification and medical therapy of pulmonary arterial hypertension
Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01889-2018 · Cited by 819
Soon, E., Holmes, A. M., Treacy, C. M., Doughty, N. J., Southgate, L., Machado, R. D., Trembath, R. C., Jennings, S., Barker, L., Nicklin, P., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.933762 · Cited by 802
Endothelial Dysfunction in Pulmonary Hypertension
Budhiraja, R., Tuder, R. M., & Hassoun, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000102381.57477.50 · Cited by 768
Self-citationTrembath, R. C., Thomson, J. R., Machado, R. D., Morgan, N. V., Atkinson, C., Winship, I., Simonneau, G., Galie, N., Loyd, J. E., Humbert, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450503 · Cited by 725
Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
Hassoun, P. M., Mouthon, L., Barberà, J. A., Eddahibi, S., Flores, S. C., Grimminger, F., Jones, P. L., Maitland, M. L., Michelakis, E. D., Morrell, N. W., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.006 · Cited by 710
Self-citationRisk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Boucly, A., Weatherald, J., Savale, L., Jaïs, X., Cottin, V., Prevot, G., Picard, F., de Groote, P., Jevnikar, M., Bergot, E., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00889-2017 · Cited by 697
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Waxman, A., Restrepo-Jaramillo, R., Thenappan, T., Ravichandran, A., Engel, P., Bajwa, A., Allen, R., Feldman, J., Argula, R., Smith, P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2008470 · Cited by 666
Hoeper, M. M., Kramer, T., Pan, Z., Eichstaedt, C. A., Spiesshoefer, J., Benjamin, N., Olsson, K. M., Meyer, K., Vizza, C. D., Vonk-Noordegraaf, A., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00740-2017 · Cited by 660
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
Galie, N., Manes, A., Negro, L., Palazzini, M., Bacchi-Reggiani, M. L., & Branzi, A. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp022 · Cited by 651
Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Humbert, M., McLaughlin, V., Gibbs, J. S. R., Gomberg-Maitland, M., Hoeper, M. M., Preston, I. R., Souza, R., Waxman, A., Escribano Subias, P., Feldman, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2024277 · Cited by 608
Hoeper, M. M., Barst, R. J., Bourge, R. C., Feldman, J., Frost, A. E., Galié, N., Gómez-Sánchez, M. A., Grimminger, F., Grünig, E., Hassoun, P. M., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000765 · Cited by 574
Self-citationVonk Noordegraaf, A., Chin, K. M., Haddad, F., Hassoun, P. M., Hemnes, A. R., Hopkins, S. R., Kawut, S. M., Langleben, D., Lumens, J., & Naeije, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01900-2018 · Cited by 569
Self-citationFrank, T. D., Carter, A., Jahagirdar, D., Biehl, M. H., Douwes-Schultz, D., Larson, S. L., Arora, M., Dwyer-Lindgren, L., Steuben, K. M., Abbastabar, H., et al. (2019) · The Lancet HIV · doi:10.1016/s2352-3018(19)30196-1 · Cited by 568
Kylhammar, D., Kjellström, B., Hjalmarsson, C., Jansson, K., Nisell, M., Söderberg, S., Wikström, G., & Rådegran, G. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx257 · Cited by 540
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
Long, L., Ormiston, M. L., Yang, X., Southwood, M., Gräf, S., Machado, R. D., Mueller, M., Kinzel, B., Yung, L. M., Wilkinson, J. M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3877 · Cited by 513
A Novel Channelopathy in Pulmonary Arterial Hypertension
Ma, L., Roman-Campos, D., Austin, E. D., Eyries, M., Sampson, K. S., Soubrier, F., Germain, M., Trégouët, D.-A., Borczuk, A., Rosenzweig, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211097 · Cited by 477
Genetics and genomics of pulmonary arterial hypertension
Morrell, N. W., Aldred, M. A., Chung, W. K., Elliott, C. G., Nichols, W. C., Soubrier, F., Trembath, R. C., & Loyd, J. E. (2019) · European Respiratory Journal · doi:10.1183/13993003.01899-2018 · Cited by 475
Ryan, J. J., & Archer, S. L. (2014) · Circulation Research · doi:10.1161/circresaha.113.301129 · Cited by 471
Hoeper, M. M., Huscher, D., Ghofrani, H. A., Delcroix, M., Distler, O., Schweiger, C., Grunig, E., Staehler, G., Rosenkranz, S., Halank, M., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.026 · Cited by 466
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension
Eyries, M., Montani, D., Girerd, B., Perret, C., Leroy, A., Lonjou, C., Chelghoum, N., Coulet, F., Bonnet, D., Dorfmüller, P., et al. (2014) · Nature Genetics · doi:10.1038/ng.2844 · Cited by 452
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension
Spiekerkoetter, E., Tian, X., Cai, J., Hopper, R. K., Sudheendra, D., Li, C. G., El-Bizri, N., Sawada, H., Haghighat, R., Chan, R., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65592 · Cited by 449
Wu, W., He, J., & Shao, X. (2020) · Medicine · doi:10.1097/md.0000000000020593 · Cited by 415
Fijalkowska, A., Kurzyna, M., Torbicki, A., Szewczyk, G., Florczyk, M., Pruszczyk, P., & Szturmowicz, M. (2006) · Chest · doi:10.1378/chest.129.5.1313 · Cited by 407
Inflammation in Pulmonary Arterial Hypertension
Price, L. C., Wort, S. J., Perros, F., Dorfmüller, P., Huertas, A., Montani, D., Cohen-Kaminsky, S., & Humbert, M. (2012) · Chest · doi:10.1378/chest.11-0793 · Cited by 403
Primary pulmonary hypertension
Dresdale, D. T., Schultz, M., & Michtom, R. J. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90020-4 · Cited by 399
Kawut, S. M., Lima, J. A. C., Barr, R. G., Chahal, H., Jain, A., Tandri, H., Praestgaard, A., Bagiella, E., Kizer, J. R., Johnson, W. C., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.985515 · Cited by 390
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
Gräf, S., Haimel, M., Bleda, M., Hadinnapola, C., Southgate, L., Li, W., Hodgson, J., Liu, B., Salmon, R. M., Southwood, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03672-4 · Cited by 380
Austin, E. D., Ma, L., LeDuc, C., Berman Rosenzweig, E., Borczuk, A., Phillips, J. A., Palomero, T., Sumazin, P., Kim, H. R., Talati, M. H., et al. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.111.961888 · Cited by 378
Olsson, K. M., Delcroix, M., Ghofrani, H. A., Tiede, H., Huscher, D., Speich, R., Grünig, E., Staehler, G., Rosenkranz, S., Halank, M., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.004526 · Cited by 372
RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension
Vanderpool, R. R., Pinsky, M. R., Naeije, R., Deible, C., Kosaraju, V., Bunner, C., Mathier, M. A., Lacomis, J., Champion, H. C., & Simon, M. A. (2015) · Heart · doi:10.1136/heartjnl-2014-306142 · Cited by 354
Fayyaz, A. U., Edwards, W. D., Maleszewski, J. J., Konik, E. A., DuBrock, H. M., Borlaug, B. A., Frantz, R. P., Jenkins, S. M., & Redfield, M. M. (2018) · Circulation · doi:10.1161/circulationaha.117.031608 · Cited by 351
Lahm, T., Douglas, I. S., Archer, S. L., Bogaard, H. J., Chesler, N. C., Haddad, F., Hemnes, A. R., Kawut, S. M., Kline, J. A., Kolb, T. M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1160st · Cited by 343
Self-citationAdvances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
Humbert, M., Lau, E. M. T., Montani, D., Jaïs, X., Sitbon, O., & Simonneau, G. (2014) · Circulation · doi:10.1161/circulationaha.114.006974 · Cited by 342
Evaluation of Pulmonary Artery Stiffness in Pulmonary Hypertension With Cardiac Magnetic Resonance
Sanz, J., Kariisa, M., Dellegrottaglie, S., Prat-González, S., Garcia, M. J., Fuster, V., & Rajagopalan, S. (2009) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2008.08.007 · Cited by 322
Miller, W. L., Grill, D. E., & Borlaug, B. A. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.05.001 · Cited by 318
Pulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension
Perros, F., Dorfmüller, P., Montani, D., Hammad, H., Waelput, W., Girerd, B., Raymond, N., Mercier, O., Mussot, S., Cohen-Kaminsky, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0927oc · Cited by 308
Molecular genetic framework underlying pulmonary arterial hypertension
Southgate, L., Machado, R. D., Gräf, S., & Morrell, N. W. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0242-x · Cited by 301
Gorter, T. M., Hoendermis, E. S., van Veldhuisen, D. J., Voors, A. A., Lam, C. S. P., Geelhoed, B., Willems, T. P., & van Melle, J. P. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.630 · Cited by 300
Transforming Growth Factor-β Receptor Mutations and Pulmonary Arterial Hypertension in Childhood
Harrison, R. E., Berger, R., Haworth, S. G., Tulloh, R., Mache, C. J., Morrell, N. W., Aldred, M. A., & Trembath, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000153798.78540.87 · Cited by 241
Jacobs, W., van de Veerdonk, M. C., Trip, P., de Man, F., Heymans, M. W., Marcus, J. T., Kawut, S. M., Bogaard, H.-J., Boonstra, A., & Vonk Noordegraaf, A. (2014) · Chest · doi:10.1378/chest.13-1291 · Cited by 231
Schistosomiasis — Assessing Progress toward the 2020 and 2025 Global Goals
Deol, A. K., Fleming, F. M., Calvo-Urbano, B., Walker, M., Bucumi, V., Gnandou, I., Tukahebwa, E. M., Jemu, S., Mwingira, U. J., Alkohlani, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812165 · Cited by 225
Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension
Sweatt, A. J., Hedlin, H. K., Balasubramanian, V., Hsi, A., Blum, L. K., Robinson, W. H., Haddad, F., Hickey, P. M., Condliffe, R., Lawrie, A., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313911 · Cited by 217
Kerstjens-Frederikse, W. S., Bongers, E. M. H. F., Roofthooft, M. T. R., Leter, E. M., Douwes, J. M., Van Dijk, A., Vonk-Noordegraaf, A., Dijk-Bos, K. K., Hoefsloot, L. H., Hoendermis, E. S., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101152 · Cited by 216
EIF2AK4 Mutations in Pulmonary Capillary Hemangiomatosis
Best, D. H., Sumner, K. L., Austin, E. D., Chung, W. K., Brown, L. M., Borczuk, A. C., Rosenzweig, E. B., Bayrak-Toydemir, P., Mao, R., Cahill, B. C., et al. (2014) · Chest · doi:10.1378/chest.13-2366 · Cited by 214
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
Campo, A., Mathai, S. C., Le Pavec, J., Zaiman, A. L., Hummers, L. K., Boyce, D., Housten, T., Lechtzin, N., Chami, H., Girgis, R. E., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00148310 · Cited by 205
Self-citationVentetuolo, C. E., Ouyang, P., Bluemke, D. A., Tandri, H., Barr, R. G., Bagiella, E., Cappola, A. R., Bristow, M. R., Johnson, C., Kronmal, R. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201007-1027oc · Cited by 199
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension
Nasim, M. T., Ogo, T., Ahmed, M., Randall, R., Chowdhury, H. M., Snape, K. M., Bradshaw, T. Y., Southgate, L., Lee, G. J., Jackson, I., et al. (2011) · Human Mutation · doi:10.1002/humu.21605 · Cited by 192
Zamanian, R. T., Badesch, D., Chung, L., Domsic, R. T., Medsger, T., Pinckney, A., Keyes-Elstein, L., D’Aveta, C., Spychala, M., White, R. J., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3481oc · Cited by 186
Self-citationHemnes, A. R., Beck, G. J., Newman, J. H., Abidov, A., Aldred, M. A., Barnard, J., Berman Rosenzweig, E., Borlaug, B. A., Chung, W. K., Comhair, S. A. A., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311737 · Cited by 174
Self-citationRhodes, C. J., Wharton, J., Ghataorhe, P., Watson, G., Girerd, B., Howard, L. S., Gibbs, J. S. R., Condliffe, R., Elliot, C. A., Kiely, D. G., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30161-3 · Cited by 160
Zhu, N., Welch, C. L., Wang, J., Allen, P. M., Gonzaga-Jauregui, C., Ma, L., King, A. K., Krishnan, U., Rosenzweig, E. B., Ivy, D. D., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0566-x · Cited by 158
Trip, P., Kind, T., van de Veerdonk, M. C., Marcus, J. T., de Man, F. S., Westerhof, N., & Noordegraaf, A. V. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.09.022 · Cited by 154
Hsu, S., Kokkonen-Simon, K. M., Kirk, J. A., Kolb, T. M., Damico, R. L., Mathai, S. C., Mukherjee, M., Shah, A. A., Wigley, F. M., Margulies, K. B., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033147 · Cited by 153
Self-citationAminorex and the pulmonary circulation
Kay, J. M., Smith, P. E., & Heath, D. (1971) · Thorax · doi:10.1136/thx.26.3.262 · Cited by 152
Pulmonary hypertension in systemic sclerosis: different phenotypes
Launay, D., Sobanski, V., HACHULLA, E., & Humbert, M. J. C. (2017) · European Respiratory Review · doi:10.1183/16000617.0056-2017 · Cited by 150
Potus, F., Pauciulo, M. W., Cook, E. K., Zhu, N., Hsieh, A., Welch, C. L., Shen, Y., Tian, L., Lima, P., Mewburn, J. D., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044320 · Cited by 133
Self-citationBuys, R., Ávila, A., & Cornelissen, V. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0031-1 · Cited by 102
Zhu, N., Swietlik, E. M., Welch, C. L., Pauciulo, M. W., Hagen, J., Zhou, X., Guo, Y., Karten, J., Pandya, D., Tilly, T., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00891-1 · Cited by 98
Swift, A. J., Lu, H., Uthoff, J., Garg, P., Cogliano, M., Taylor, J. C., Metherall, P., Zhou, S., Johns, C., Alabed, S., et al. (2020) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaa001 · Cited by 96
Galiè, N., Jansa, P., Pulido, T., Channick, R. N., Delcroix, M., Ghofrani, H. A., Brun, F. L., Mehta, S., Perchenet, L., Rubin, L. J., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx025 · Cited by 81
Rain, S., Bós, D. D. S. G., Handoko, M. L., Westerhof, N., Stienen, G. J. M., Ottenheijm, C. A. C., Goebel, M., Dorfmüller, P., Guignabert, C., Humbert, M. J. C., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000716 · Cited by 77
Risk stratification in pulmonary arterial hypertension using Bayesian analysis
Kanwar, M. K., Gomberg‐Maitland, M., Hoeper, M. M., Pausch, C., Pittrow, D., Strange, G. A., Anderson, J., Zhao, C., Scott, J. V., Drużdżel, M. J., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00008-2020 · Cited by 52
[Pathology of primary pulmonary hypertension].
Chazova, I. E., Vs, Z., Sp, B., & Mareev, V. I. (1993) · PubMed · Cited by 50
Benza, R. L., Farber, H. W., Frost, A., Ghofrani, H. A., Gómez‐Sánchez, M. Á., Langleben, D., Rosenkranz, S., Busse, D., Meier, C., Nikkho, S. M., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.11.006 · Cited by 38
Advanced imaging in pulmonary hypertension: emerging techniques and applications
Rengier, F., Melzig, C., Derlin, T., Marra, A. M., & Vogel‐Claussen, J. (2018) · International journal of cardiac imaging · doi:10.1007/s10554-018-1448-4 · Cited by 32
Precapillary Pulmonary Hypertension and Sleep-Disordered Breathing: Is There a Link?
Thurnheer, R., Ulrich, S., & Bloch, K. E. (2016) · Respiration · doi:10.1159/000452957 · Cited by 30
Richards, D. W. (1957) · American Heart Journal · doi:10.1016/0002-8703(57)90143-6 · Cited by 14
Cited by
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Hoeper, M. M., Badesch, D. B., Ghofrani, H. A., Gibbs, J. S. R., Gomberg-Maitland, M., McLaughlin, V. V., Preston, I. R., Souza, R., Waxman, A. B., Grünig, E., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2213558 · Cited by 728
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
Stolz, D., Mkorombindo, T., Schumann, D. M., Agusti, A., Ash, S. Y., Bafadhel, M., Bai, C., Chalmers, J. D., Criner, G. J., Dharmage, S. C., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01273-9 · Cited by 681
Houston, B. A., Brittain, E. L., & Tedford, R. J. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2207410 · Cited by 280
Insights into bone morphogenetic proteins in cardiovascular diseases
Ye, D., Liu, Y., Pan, H., Feng, Y., Lu, X., Gan, L., Wan, J., & Ye, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125642 · Cited by 37
Metadata
- Authors
- Hassoun, P. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-12-16
- Volume
- 385
- Issue
- 25
- Pages
- 2361-2376
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4205279500
- Cited by
- 693
- References
- 84
- FWCI
- 59.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.